Small CDMO

Syngene International Ltd.

SYNGENE

Market Cap
₹17,378 Cr.
P/E
54.87

Syngene International Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
17,378 Cr
PE
PE
54.87
Prom Holding
Prom Holding
52.68 %
ROE (%)
ROE (%)
6.54
ROCE (%)
ROCE (%)
9.93
Div Yield (%)
Div Yield (%)
0.29
Sales
Sales
3,738 Cr
OPM (%)
OPM (%)
-
Debt to Equity
Debt to Equity
0.00
Institutions
Institutions
40.35 %
Individual < 2 lac
Individual < 2 lac
4.21 %
No. of Shareholders
No. of Shareholders
1.36 L
View more
Edit Ratio's

About

Syngene International Limited, founded in 1993, is a globally recognized contract research and… Read more
Low
380
52W Range
High
729
  • Syngene Internatl.
  • Piramal Pharma
  • Laurus Labs
  • TJI Pharma - API & CRAMS

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • HLE Glascoat Ltd.

    Customers

    • Procter & Gamble Health Ltd.
    • Amgen
    • Bristol-Myers Squibb
    • Abbvie
    • Albireo

    FAQs on Syngene International Ltd. Business

    Syngene International Limited, established in 1993, is a renowned CRMO offering integrated drug discovery and development services. With various certifications and accreditations, the company provides support from lead generation to clinical supplies.

    Syngene Internatl. major competitors are Piramal Pharma, Laurus Labs, Sun Pharma Adv. Res, Dishman Carbogen Amc, Zenotech Labs., Jeevan Scientific, Vivo Bio Tech.
    Market Cap of Syngene Internatl. is ₹17,772 Crs.
    While the median market cap of its peers are ₹3,082 Crs.

    Syngene Internatl. seems to be less financially stable compared to its competitors.
    Altman Z score of Syngene Internatl. is 6.74 and is ranked 4 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Jan Mar Jul Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Dec
    Investor Presentation Jan Apr Mar Jul Sep Nov Dec Jun Sep Dec Mar Jun Sep Dec Mar Apr Jun Jul Sep Dec Jan Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
    Conference Call Jan Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Syngene International Ltd.
    Synegene -- A Hidden Platform ? - SOIC
    Syngene - A Giant In The Making - MJK Investments
    View the discussion on ValuePickr
    Least Understood Fact About Syngene By Aditya Khemka - Wealth Podcast
    Detailed Analysis on the business of Syngene International - India’s largest listed CRO - Value Educator
    Jubilant vs Syngene in CDMO - UnseenValue
    []
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material